Model for End-Stage Liver Disease: End of the First Decade

Sumeet K. Asrani, W. Ray Kim

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The Model for End-stage Liver Disease (MELD) score is the basis for allocation of liver allografts for transplantation in the United States. The MELD score, as an objective scale of disease severity, is also used in the management of patients with chronic liver disease in the nontransplant setting. Several models have been proposed to improve the MELD score. The authors believe that the MELD score is, by design, continually evolving and lends itself to continued refinement and improvement to serve as a metric to optimize organ allocation in the future.

Original languageEnglish (US)
Pages (from-to)685-698
Number of pages14
JournalClinics in Liver Disease
Volume15
Issue number4
DOIs
StatePublished - Nov 2011

Fingerprint

End Stage Liver Disease
Liver Transplantation
Allografts
Liver Diseases
Chronic Disease

Keywords

  • Mathematical models
  • MELD
  • Organ allocation
  • Prognosis
  • Survival
  • Waiting-list mortality

ASJC Scopus subject areas

  • Hepatology

Cite this

Model for End-Stage Liver Disease : End of the First Decade. / Asrani, Sumeet K.; Kim, W. Ray.

In: Clinics in Liver Disease, Vol. 15, No. 4, 11.2011, p. 685-698.

Research output: Contribution to journalArticle

Asrani, Sumeet K. ; Kim, W. Ray. / Model for End-Stage Liver Disease : End of the First Decade. In: Clinics in Liver Disease. 2011 ; Vol. 15, No. 4. pp. 685-698.
@article{19c4f28011ba42f6ad287fbd36102a97,
title = "Model for End-Stage Liver Disease: End of the First Decade",
abstract = "The Model for End-stage Liver Disease (MELD) score is the basis for allocation of liver allografts for transplantation in the United States. The MELD score, as an objective scale of disease severity, is also used in the management of patients with chronic liver disease in the nontransplant setting. Several models have been proposed to improve the MELD score. The authors believe that the MELD score is, by design, continually evolving and lends itself to continued refinement and improvement to serve as a metric to optimize organ allocation in the future.",
keywords = "Mathematical models, MELD, Organ allocation, Prognosis, Survival, Waiting-list mortality",
author = "Asrani, {Sumeet K.} and Kim, {W. Ray}",
year = "2011",
month = "11",
doi = "10.1016/j.cld.2011.08.009",
language = "English (US)",
volume = "15",
pages = "685--698",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Model for End-Stage Liver Disease

T2 - End of the First Decade

AU - Asrani, Sumeet K.

AU - Kim, W. Ray

PY - 2011/11

Y1 - 2011/11

N2 - The Model for End-stage Liver Disease (MELD) score is the basis for allocation of liver allografts for transplantation in the United States. The MELD score, as an objective scale of disease severity, is also used in the management of patients with chronic liver disease in the nontransplant setting. Several models have been proposed to improve the MELD score. The authors believe that the MELD score is, by design, continually evolving and lends itself to continued refinement and improvement to serve as a metric to optimize organ allocation in the future.

AB - The Model for End-stage Liver Disease (MELD) score is the basis for allocation of liver allografts for transplantation in the United States. The MELD score, as an objective scale of disease severity, is also used in the management of patients with chronic liver disease in the nontransplant setting. Several models have been proposed to improve the MELD score. The authors believe that the MELD score is, by design, continually evolving and lends itself to continued refinement and improvement to serve as a metric to optimize organ allocation in the future.

KW - Mathematical models

KW - MELD

KW - Organ allocation

KW - Prognosis

KW - Survival

KW - Waiting-list mortality

UR - http://www.scopus.com/inward/record.url?scp=80054934572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054934572&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2011.08.009

DO - 10.1016/j.cld.2011.08.009

M3 - Article

C2 - 22032523

AN - SCOPUS:80054934572

VL - 15

SP - 685

EP - 698

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 4

ER -